# Drug Combinations of Atovaquone-Proguanil (AP) With ACT

> **NCT03726593** · PHASE4 · UNKNOWN · sponsor: **Armed Forces Research Institute of Medical Sciences, Thailand** · enrollment: 252 (estimated)

## Conditions studied

- Plasmodium Falciparum Malaria (Drug Resistant)

## Interventions

- **DRUG:** Artesunate and Pyronaridine
- **DRUG:** Atovaquone Proguanil and Artesunate Pyronaridine
- **DRUG:** Atovaquone Proguanil and Artesunate Mefloquine

## Key facts

- **NCT ID:** NCT03726593
- **Lead sponsor:** Armed Forces Research Institute of Medical Sciences, Thailand
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-10-04
- **Primary completion:** 2022-08-30
- **Final completion:** 2022-12-30
- **Target enrollment:** 252 (ESTIMATED)
- **Last updated:** 2021-03-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03726593

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03726593, "Drug Combinations of Atovaquone-Proguanil (AP) With ACT". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03726593. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*